Search | VHL Search Portal

1.

Characterization and stabilization of the α-L-fucosidase set from Lacticaseibacillus rhamnosus INIA P603.

Curiel, José Antonio; Peirotén, Ángela; Langa, Susana; de Vega, Estela; Blasco, Laura; Landete, José María.

Appl Microbiol Biotechnol ; 106(24): 8067-8077, 2022 Dec.

Article in English | MEDLINE | ID: mdl-36370158

2.

SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer.

Pascual, Tomas; Cejalvo, Juan M; Oliveira, Mafalda; Vidal, Maria; Vega, Estela; Ganau, Sergi; Julve, Ana; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begoña; la Cruz-Merino, Luis de; Juan, Manel; Ferrero-Cafiero, Juan M; Canes, Jordi; Gonzalez, Xavier; Villagrasa, Patricia; Prat, Aleix.

Future Oncol ; 16(24): 1801-1813, 2020 Aug.

Article in English | MEDLINE | ID: mdl-32633563

3.

Production of recombinant glycosidases fused with Usp45 and SpaX to avoid the purification and immobilization stages.

Curiel, José Antonio; de Vega, Estela; Langa, Susana; Peirotén, Ángela; Landete, José María.

Enzyme Microb Technol ; 178: 110445, 2024 Aug.

Article in English | MEDLINE | ID: mdl-38581868

4.

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.

Kuemmel, Sherko; Campone, Mario; Loirat, Delphine; Lopez, Rafael Lopez; Beck, J Thaddeus; De Laurentiis, Michelino; Im, Seock-Ah; Kim, Sung-Bae; Kwong, Ava; Steger, Guenther G; Adelantado, Esther Zamora; Duhoux, Francois P; Greil, Richard; Kuter, Irene; Lu, Yen-Shen; Tibau, Ariadna; Özgüroglu, Mustafa; Scholz, Christian W; Singer, Christian F; Vega, Estela; Wimberger, Pauline; Zamagni, Claudio; Couillebault, Xuan-Mai; Fan, Liqiong; Guerreiro, Nelson; Mataraza, Jennifer; Sand-Dejmek, Janna; Chan, Arlene.

Clin Cancer Res ; 28(1): 106-115, 2022 01 01.

Article in English | MEDLINE | ID: mdl-34615719

5.

Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination.

Ciérvide, Raquel; Montero, Ángel; García-Rico, Eduardo; García-Aranda, Mariola; Herrero, Mercedes; Skaarup, Jessica; Benassi, Leticia; Barrera, Maria José; Vega, Estela; Rojas, Beatriz; Bratos, Raquel; Luna, Ana; Parras, Manuela; López, María; Delgado, Ana; Quevedo, Paloma; Castilla, Silvia; Feyjoo, Margarita; Higueras, Ana; Prieto, Mario; Suarez-Gauthier, Ana; Garcia-Cañamaque, Lina; Escolán, Nieves; Álvarez, Beatriz; Chen, Xin; Alonso, Rosa; López, Mercedes; Hernando, Ovidio; Valero, Jeannette; Sánchez, Emilio; Ciruelos, Eva; Rubio, Carmen.

Cancers (Basel) ; 14(18)2022 Sep 19.

Article in English | MEDLINE | ID: mdl-36139688

6.

Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial.

Ciruelos, Eva; Villagrasa, Patricia; Pascual, Tomás; Oliveira, Mafalda; Pernas, Sonia; Paré, Laia; Escrivá-de-Romaní, Santiago; Manso, Luis; Adamo, Barbara; Martínez, Eduardo; Cortés, Javier; Vazquez, Silvia; Perelló, Antonia; Garau, Isabel; Melé, Mireia; Martínez, Noelia; Montaño, Alvaro; Bermejo, Begoña; Morales, Serafin; Echarri, María J; Vega, Estela; González-Farré, Blanca; Martínez, Débora; Galván, Patricia; Canes, Jordi; Nuciforo, Paolo; Gonzalez, Xavier; Prat, Aleix.

Clin Cancer Res ; 26(22): 5820-5829, 2020 11 15.

Article in English | MEDLINE | ID: mdl-32938620

7.

Palbociclib combined with endocrine therapy in heavily pretreated HR⁺/HER2^- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).

Manso, Luis; Hernando, Cristina; Galán, María; Oliveira, Mafalda; Cabrera, Miguel A; Bratos, Raquel; Rodríguez, César A; Ruiz-Borrego, Manuel; Blanch, Salvador; Llombart-Cussac, Antonio; Delgado-Mingorance, Juan I; Álvarez-Busto, Iñaki; Gallegos, Isabel; González-Cortijo, Lucía; Morales, Serafín; Aguirre, Elena; Hernando, Blanca A; Ballesteros, Ana; Alés-Martínez, José E; Reboredo, Cristina; Oltra, Amparo; González-Cao, María; Santisteban, Marta; Malón, Diego; Echeverría, Isabel; García-Garre, Elisa; Vega, Estela; Servitja, Sònia; Andrés, Raquel; Robles, Carlos E; López, Rafael; Galve, Elena; Echarri, María J; Legeren, Marta; Moreno, Fernando.

Breast ; 54: 286-292, 2020 Dec.

Article in English | MEDLINE | ID: mdl-33242755

8.

[Evaluation of the validity of Diagnostic Interview Schedule for Children IV (DISC IV) in the city of Buenos Aires]. / Evaluación de la validez de los diagnósticos DSM IV realizados con un Instrumento Estructurado, el NIMH DISC-IV, en la Ciudad de Buenos Aires.

Kunst, Gabriel; Blidner, Jorge; Esrubilsky, Valentina; Longarela, Hugo; Vega, Estela.

Vertex ; 20(86): 245-51, 2009.

Article in Spanish | MEDLINE | ID: mdl-19812792

9.

Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer.

Cubillo, Antonio; Álvarez-Gallego, Rafael; Muñoz, Manuel; Pond, Gregory; Perea, Sofía; Sánchez, Gema; Martin, María; Rodríguez-Pascual, Jesús; Garralda, Elena; Vega, Estela; de Vicente, Emilio; Quijano, Yolanda; Muñoz, César; Ugidos, Lisardo; Toledo, Rodrigo A; Hidalgo, Manuel.

Am J Clin Oncol ; 42(1): 56-59, 2019 01.

Article in English | MEDLINE | ID: mdl-29975196

10.

Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies.

Toledo, Rodrigo A; Garralda, Elena; Mitsi, Maria; Pons, Tirso; Monsech, Jorge; Vega, Estela; Otero, Álvaro; Albarran, Maria I; Baños, Natalia; Durán, Yolanda; Bonilla, Victoria; Sarno, Francesca; Camacho-Artacho, Marta; Sanchez-Perez, Tania; Perea, Sofia; Álvarez, Rafael; De Martino, Alba; Lietha, Daniel; Blanco-Aparicio, Carmen; Cubillo, Antonio; Domínguez, Orlando; Martínez-Torrecuadrada, Jorge L; Hidalgo, Manuel.

Clin Cancer Res ; 24(15): 3550-3559, 2018 08 01.

Article in English | MEDLINE | ID: mdl-29588308

11.

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab.

Toledo, Rodrigo A; Cubillo, Antonio; Vega, Estela; Garralda, Elena; Alvarez, Rafael; de la Varga, Lisardo U; Pascual, Jesús R; Sánchez, Gema; Sarno, Francesca; Prieto, Susana H; Perea, Sofía; Lopéz-Casas, Pedro P; López-Ríos, Fernando; Hidalgo, Manuel.

Oncotarget ; 8(21): 35289-35300, 2017 May 23.

Article in English | MEDLINE | ID: mdl-27852040

12.

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

Ciruelos, Eva; Pascual, Tomás; Arroyo Vozmediano, María Luisa; Blanco, Marta; Manso, Luis; Parrilla, Lucía; Muñoz, Cesar; Vega, Estela; Calderón, Monica Jackelin; Sancho, Blanca; Cortes-Funes, Hernán.

Breast ; 23(3): 201-8, 2014 Jun.

Article in English | MEDLINE | ID: mdl-24589524

13.

Novel approach for the determination of volatile compounds in processed onion by headspace gas chromatography-mass spectrometry (HS GC-MS).

Colina-Coca, Clara; González-Peña, Diana; Vega, Estela; de Ancos, Begoña; Sánchez-Moreno, Concepción.

Talanta ; 103: 137-44, 2013 Jan 15.

Article in English | MEDLINE | ID: mdl-23200369

14.

Evaluación de la validez de los diagnósticos DSM IV realizados con un Instrumento Estructurado, el NIMH DISC-IV, en la Ciudad de Buenos Aires / Evaluation of the validity of diagnostic interview schedule for children IV (DISC IV) in the city of Buenos Aires

Kunst, Gabriel; Blidner, Jorge; Esrubilsky, Valentina; Longarela, Hugo; Vega, Estela.

Vertex rev. argent. psiquiatr ; 20(86): 245-251, jul.-ago. 2009. tab

Article in Spanish | BINACIS | ID: bin-124701

15.

Evaluación de la validez de los diagnósticos DSM IV realizados con un Instrumento Estructurado, el NIMH DISC-IV, en la Ciudad de Buenos Aires / Evaluation of the validity of diagnostic interview schedule for children IV (DISC IV) in the city of Buenos Aires

Kunst, Gabriel; Blidner, Jorge; Esrubilsky, Valentina; Longarela, Hugo; Vega, Estela.

Vertex rev. argent. psiquiatr ; 20(86): 245-251, jul.-ago. 2009. tab

Article in Spanish | LILACS | ID: lil-540550

16.

Crisis y Suicicio

Calistri, Teresa; Frigerio, Ricardo; Gravano, Amelia Beatriz; Jones, Aberto; Sabbioni de Vega, Estela; Saimovici, Edmundo; Trotta, María Stella.

Buenos Aires; Grupo de investigación sobre Crisis y Suicidio;A.P.A; 1; 1998. 155 p. (82241).

Monography in Spanish | BINACIS | ID: bin-82241

17.

Crisis y Suicicio

Calistri, Teresa; Frigerio, Ricardo; Gravano, Amelia Beatriz; Jones, Aberto; Sabbioni de Vega, Estela; Saimovici, Edmundo; Trotta, María Stella.

Buenos Aires; Grupo de investigación sobre Crisis y Suicidio;A.P.A; 1; 1998. 155 p.

Monography in Spanish | LILACS-Express | ID: biblio-1204529

18.

Crisis y suicidio

Calisti, Teresa; Frigerio, Ricardo; Gravano, Amelia Beatriz; Jones, Alberto; Sabbioni de Vega, Estela; Saimovici, Edmundo; Trotta, María Stella; Yampey, Nasin; Asociación Psicoanalítica Argentina.

Buenos Aires; Grupo de Investigacion Sobre Crisis y Suicidio; 1a. ed; 1998. 155 p. 22 cm. (77594).

in Spanish | BINACIS | ID: bin-77594

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

Characterization and stabilization of the α-L-fucosidase set from Lacticaseibacillus rhamnosus INIA P603.

SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer.

Production of recombinant glycosidases fused with Usp45 and SpaX to avoid the purification and immobilization stages.

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.

Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination.

Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial.

Palbociclib combined with endocrine therapy in heavily pretreated HR⁺/HER2^- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).

[Evaluation of the validity of Diagnostic Interview Schedule for Children IV (DISC IV) in the city of Buenos Aires]. / Evaluación de la validez de los diagnósticos DSM IV realizados con un Instrumento Estructurado, el NIMH DISC-IV, en la Ciudad de Buenos Aires.

Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer.

Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies.

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab.

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

Novel approach for the determination of volatile compounds in processed onion by headspace gas chromatography-mass spectrometry (HS GC-MS).

Evaluación de la validez de los diagnósticos DSM IV realizados con un Instrumento Estructurado, el NIMH DISC-IV, en la Ciudad de Buenos Aires / Evaluation of the validity of diagnostic interview schedule for children IV (DISC IV) in the city of Buenos Aires

Evaluación de la validez de los diagnósticos DSM IV realizados con un Instrumento Estructurado, el NIMH DISC-IV, en la Ciudad de Buenos Aires / Evaluation of the validity of diagnostic interview schedule for children IV (DISC IV) in the city of Buenos Aires

Crisis y Suicicio

Crisis y Suicicio

Crisis y suicidio